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New generation of polymeric wound dressings functionalized with immunoregulatory 
antimicrobial peptides accelerate tissue regeneration and protect against infections 
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Abstract 
Medical textiles are one of the most rapidly expanding sectors in the technical textile marketing, 
and wound dressing manufacture and design is possibly its most important segment.  
In the past, traditional dressings were used to simply manage wounds. Modern dressing 
technology has evolved considerably in the last 50 years and is now based on the principle of 
creating an optimal environment, in which accelerating wound healing, tissue regeneration, and 
preventing infections are the main goals. Wound dressings are among the fastest growing 
products in the world. In 2016 the economical burden associated with these products was 
estimated at ≈ 33.1 b€, increasing 5.3% over past years. Hence, the urgency for more effective, 
target-directed and faster solutions for both acute and chronic wound care.  
Typically, acute wound healing is a well-organized process that evolves and ends in a 
predictable amount of time. Conversely, chronic wounds are a result of gradual tissue 
degradation. These are often characterized by a defective matrix and cell debris impair healing, 
high bacteria counts, prolonged inflammation and moisture imbalance. A collection of 
expensive and individualized treatments, i.e. mechanical debridement, administration of 
antibiotics and anti-inflammatory agents, use of appropriate dressing and application of drug 
therapies, is applied to treat each symptom revealed by chronic wounds. Antimicrobial 
dressings that combine both dressing and drug in their formulation have been suggested as 
potential strategies to treat chronic wounds and prevent their evolution. Lately, in view of the 
quick rising of antibiotic-resistant pathogens, antimicrobial peptides (AMPs) that display broad 
spectrum of activity and act rapidly at multiple sites within microbial cells have been described 
as next generation agents that both accelerate healing and prevent microbial colonization. 
Considering these facts, we proposed to engineer polymeric micro and nanofibrous dressings, in 
the form of mats, functionalized with AMPs endowed with immunoregulatory properties. The 
goal was, therefore, to create a single therapy formulation, which integrates biocompatible 
polymers and AMPs with an active role in the different phases of wound healing, that act on all 
barriers to acute and chronic wound care. The antimicrobial performance of these new 
generation dressings was tested against Staphylococcus aureus, Staphylococcus epidermidis and 
Escherichia coli bacteria, the most commonly found in hospital environments. Their 
hemocompatibility was also established. Preliminary data revealed the stability of the 
functionalized micro and nanofibers. Biological testing is ongoing.  
 
 
